This news is delayed by 15 minutes, sign up now to get live news & full features.
RNAZ TRANSCODE THERAPEUTICS INC
+ add to watchlist
$9.06
transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.
Mkt Cap: $8.22M
52 Week High: $22.03
P/E: 0.00
52 Week Low: $0.33
Dividend: $0.00
Shares Outstanding: 916.97k